India, Nov. 16 -- GLP-1 medicines have not only reshaped the treatment landscape for diabetes and obesity but are also demonstrating therapeutic potential extending beyond blood sugar control and weight loss. A recent FDA warning about a rare eye condition raises questions about how to balance treatment benefits against potential risks - and what happens when patients stop treatment.

What Are GLP-1 Medicines?

GLP-1 receptor agonists mimic glucagon-like peptide-1, a hormone released by the intestine. They help lower blood sugar after meals and act on areas of the brain involved in appetite and food intake.

These medicines are used to treat type 2 diabetes or help eligible patients lose excess weight and maintain weight loss. Certain medic...